Translation initiation in cancer at a glance
- PMID: 33441326
- DOI: 10.1242/jcs.248476
Translation initiation in cancer at a glance
Abstract
Cell division, differentiation and function are largely dependent on accurate proteome composition and regulated gene expression. To control this, protein synthesis is an intricate process governed by upstream signalling pathways. Eukaryotic translation is a multistep process and can be separated into four distinct phases: initiation, elongation, termination and recycling of ribosomal subunits. Translation initiation, the focus of this article, is highly regulated to control the activity and/or function of eukaryotic initiation factors (eIFs) and permit recruitment of mRNAs to the ribosomes. In this Cell Science at a Glance and accompanying poster, we outline the mechanisms by which tumour cells alter the process of translation initiation and discuss how this benefits tumour formation, proliferation and metastasis.
Keywords: Cancer; Cell signalling; Translation.
© 2021. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interestsThe authors declare no competing or financial interests.
Similar articles
-
Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):e2017715118. doi: 10.1073/pnas.2017715118. Proc Natl Acad Sci U S A. 2021. PMID: 33479166 Free PMC article.
-
Takeover of host ribosomes by divergent IRES elements.Biochem Soc Trans. 2005 Dec;33(Pt 6):1479-82. doi: 10.1042/BST0331479. Biochem Soc Trans. 2005. PMID: 16246150 Review.
-
Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis.Semin Cancer Biol. 2022 Nov;86(Pt 3):151-165. doi: 10.1016/j.semcancer.2022.04.006. Epub 2022 Apr 26. Semin Cancer Biol. 2022. PMID: 35487398 Review.
-
Protein-protein interactions required during translation.Plant Mol Biol. 2002 Dec;50(6):949-70. doi: 10.1023/a:1021220910664. Plant Mol Biol. 2002. PMID: 12516864 Review.
-
Eukaryotic translation initiation factors as promising targets in cancer therapy.Cell Commun Signal. 2020 Nov 4;18(1):175. doi: 10.1186/s12964-020-00607-9. Cell Commun Signal. 2020. PMID: 33148274 Free PMC article. Review.
Cited by
-
Advances and Breakthroughs in IRES-Directed Translation and Replication of Picornaviruses.mBio. 2023 Apr 25;14(2):e0035823. doi: 10.1128/mbio.00358-23. Epub 2023 Mar 20. mBio. 2023. PMID: 36939331 Free PMC article. Review.
-
eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma.Front Oncol. 2022 May 30;12:848346. doi: 10.3389/fonc.2022.848346. eCollection 2022. Front Oncol. 2022. PMID: 35707354 Free PMC article.
-
Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.J Med Chem. 2023 Aug 10;66(15):10734-10745. doi: 10.1021/acs.jmedchem.3c00917. Epub 2023 Jul 20. J Med Chem. 2023. PMID: 37471629 Free PMC article.
-
Circular RNAs' cap-independent translation protein and its roles in carcinomas.Mol Cancer. 2021 Sep 15;20(1):119. doi: 10.1186/s12943-021-01417-4. Mol Cancer. 2021. PMID: 34526007 Free PMC article. Review.
-
Loss-of-function cancer-linked mutations in the EIF4G2 non-canonical translation initiation factor.Life Sci Alliance. 2023 Dec 21;7(3):e202302338. doi: 10.26508/lsa.202302338. Print 2024 Mar. Life Sci Alliance. 2023. PMID: 38129098 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical